Literature DB >> 11376912

Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: a Fos study.

Gwénaëlle Catheline1, Stéphanie Le Guen, Jean-Marie Besson.   

Abstract

In a model of mononeuropathic pain (chronic constriction injury of the sciatic nerve, CCI), we have demonstrated that light touch stimuli (stroking) to the paw induced Fos-like immunoreactivity (Fos-LI) in the superficial and deep dorsal horn of the rat spinal cord (Catheline et al., Pain 80 (1999a) 347). The efficacy of opioids in neuropathic pain being controversial, we have tested the effects of morphine (0.3, 1 and 3 mg/kg intravenous, i.v.) on this spinal Fos-LI evoked by light tactile stimuli, which could be related to mechanical allodynia. Morphine did not change the level of spinal Fos-LI observed following light touch stimuli in the CCI rats (43 +/- 3, 38 +/- 7, and 37 +/- 4 Fos-LI neurones/40 microm L4-L5 section, respectively, for the three doses versus 32 +/- 4 in the control group). In contrast, the administration of 3 mg/kg of i.v. morphine reduced by 30% the number of Fos-LI neurones induced by heat stimulation (52 degrees C, 15 s duration) in CCI rats (P < 0.05) as in sham-operated rats. These effects were reversed by the systemic administration of naloxone. The lack of effect of morphine on touch-evoked Fos-LI in the superficial dorsal horn reinforces the assertion that dynamic mechanical allodynia is related to information transmitted by A-beta fibres, since opioid receptors are mainly located on thin primary afferent fibres. Our results provide a basis for a certain form of allodynia that is insensitive to morphine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376912     DOI: 10.1016/S0304-3959(01)00283-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  10 in total

1.  Intravenous lidocaine reduces ischemic pain in healthy volunteers.

Authors:  Michael A Frölich; Jason L McKeown; Mark J Worrell; Timothy J Ness
Journal:  Reg Anesth Pain Med       Date:  2010 May-Jun       Impact factor: 6.288

2.  Effects of transgene-mediated endomorphin-2 in inflammatory pain.

Authors:  Shuanglin Hao; Darren Wolfe; Joseph C Glorioso; Marina Mata; David J Fink
Journal:  Eur J Pain       Date:  2008-06-24       Impact factor: 3.931

3.  Isoliquiritigenin, an active ingredient of Glycyrrhiza, elicits antinociceptive effects via inhibition of Nav channels.

Authors:  Yuichi Miyamura; Suzuro Hitomi; Yuji Omiya; Izumi Ujihara; Shoichiro Kokabu; Yasuhiro Morimoto; Kentaro Ono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-06       Impact factor: 3.000

4.  Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

Authors:  Shuanglin Hao; Marina Mata; Darren Wolfe; Shaohua Huang; Joseph C Glorioso; David J Fink
Journal:  Ann Neurol       Date:  2005-06       Impact factor: 10.422

5.  Nerve injury-induced tactile allodynia is present in the absence of FOS labeling in retrogradely labeled post-synaptic dorsal column neurons.

Authors:  En-Tan Zhang; Michael H Ossipov; Dong-Qin Zhang; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2006-12-06       Impact factor: 6.961

6.  Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways.

Authors:  Louis P Vera-Portocarrero; En-Tan Zhang; Tamara King; Michael H Ossipov; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2006-11-22       Impact factor: 6.961

7.  Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn.

Authors:  Rita Bardoni; Vivianne L Tawfik; Dong Wang; Amaury François; Carlos Solorzano; Scott A Shuster; Papiya Choudhury; Chiara Betelli; Colleen Cassidy; Kristen Smith; Joriene C de Nooij; Françoise Mennicken; Dajan O'Donnell; Brigitte L Kieffer; C Jeffrey Woodbury; Allan I Basbaum; Amy B MacDermott; Grégory Scherrer
Journal:  Neuron       Date:  2014-02-27       Impact factor: 17.173

Review 8.  Behavioral models of pain states evoked by physical injury to the peripheral nerve.

Authors:  Linda S Sorkin; Tony L Yaksh
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain.

Authors:  A B Intondi; M N Dahlgren; M A Eilers; B K Taylor
Journal:  Pain       Date:  2007-10-31       Impact factor: 6.961

10.  HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.

Authors:  Shuanglin Hao; Marina Mata; Joseph C Glorioso; David J Fink
Journal:  Mol Pain       Date:  2006-02-17       Impact factor: 3.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.